Yu V - Search Results

1

Epigenetics: an emerging technology in the diagnosis and treatment of cancer.

Stebbing J, Bower M, Syed N, Smith P, Yu V, Crook T. Stebbing J, et al. Among authors: yu v. Pharmacogenomics. 2006 Jul;7(5):747-57. doi: 10.2217/14622416.7.5.747. Pharmacogenomics. 2006. PMID: 16886899 Review.

2

Unusual presentation of Lynch Syndrome.

Yu VP, Novelli M, Payne SJ, Fisher S, Barnetson RA, Frayling IM, Barrett A, Goudie D, Ardern-Jones A, Eeles R, Shanley S. Yu VP, et al. Hered Cancer Clin Pract. 2009 Jun 3;7(1):12. doi: 10.1186/1897-4287-7-12. Hered Cancer Clin Pract. 2009. PMID: 19493351 Free PMC article.

3

Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation.

Yu VP, Koehler M, Steinlein C, Schmid M, Hanakahi LA, van Gool AJ, West SC, Venkitaraman AR. Yu VP, et al. Genes Dev. 2000 Jun 1;14(11):1400-6. Genes Dev. 2000. PMID: 10837032 Free PMC article.

4

The G67E mutation in hMLH1 is associated with an unusual presentation of Lynch syndrome.

Clyne M, Offman J, Shanley S, Virgo JD, Radulovic M, Wang Y, Ardern-Jones A, Eeles R, Hoffmann E, Yu VP. Clyne M, et al. Among authors: yu vp. Br J Cancer. 2009 Jan 27;100(2):376-80. doi: 10.1038/sj.bjc.6604860. Epub 2009 Jan 13. Br J Cancer. 2009. PMID: 19142183 Free PMC article.

5

Caretaker Brca1: keeping the genome in the straight and narrow.

Yu V. Yu V. Breast Cancer Res. 2000;2(2):82-5. doi: 10.1186/bcr37. Epub 2000 Feb 7. Breast Cancer Res. 2000. PMID: 11250695 Free PMC article. Review.

6

The CDK subunit CKS2 counteracts CKS1 to control cyclin A/CDK2 activity in maintaining replicative fidelity and neurodevelopment.

Frontini M, Kukalev A, Leo E, Ng YM, Cervantes M, Cheng CW, Holic R, Dormann D, Tse E, Pommier Y, Yu V. Frontini M, et al. Among authors: yu v. Dev Cell. 2012 Aug 14;23(2):356-70. doi: 10.1016/j.devcel.2012.06.018. Dev Cell. 2012. PMID: 22898779 Free PMC article.

7

The Cks1/Cks2 axis fine-tunes Mll1 expression and is crucial for MLL-rearranged leukaemia cell viability.

Grey W, Ivey A, Milne TA, Haferlach T, Grimwade D, Uhlmann F, Voisset E, Yu V. Grey W, et al. Among authors: yu v. Biochim Biophys Acta Mol Cell Res. 2018 Jan;1865(1):105-116. doi: 10.1016/j.bbamcr.2017.09.009. Epub 2017 Sep 20. Biochim Biophys Acta Mol Cell Res. 2018. PMID: 28939057 Free PMC article.

8

CKS proteins protect mitochondrial genome integrity by interacting with mitochondrial single-stranded DNA-binding protein.

Radulovic M, Crane E, Crawford M, Godovac-Zimmermann J, Yu VP. Radulovic M, et al. Mol Cell Proteomics. 2010 Jan;9(1):145-52. doi: 10.1074/mcp.M900078-MCP200. Epub 2009 Sep 28. Mol Cell Proteomics. 2010. PMID: 19786724 Free PMC article.

9

Involvement of Brca2 in DNA repair.

Patel KJ, Yu VP, Lee H, Corcoran A, Thistlethwaite FC, Evans MJ, Colledge WH, Friedman LS, Ponder BA, Venkitaraman AR. Patel KJ, et al. Among authors: yu vp. Mol Cell. 1998 Feb;1(3):347-57. doi: 10.1016/s1097-2765(00)80035-0. Mol Cell. 1998. PMID: 9660919 Free article.

10

Thymic lymphomas in mice with a truncating mutation in Brca2.

Friedman LS, Thistlethwaite FC, Patel KJ, Yu VP, Lee H, Venkitaraman AR, Abel KJ, Carlton MB, Hunter SM, Colledge WH, Evans MJ, Ponder BA. Friedman LS, et al. Among authors: yu vp. Cancer Res. 1998 Apr 1;58(7):1338-43. Cancer Res. 1998. PMID: 9537225

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

969 results

Search Page